The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
MicroRNAs in cancer: biomarkers, functions and therapy
Open accessAbstract
The emergence of microRNAs has been one of the defining developments in cancer biology over the past decade, and the explosion of knowledge in this area has brought forward new diagnostic and therapeutic opportunities. The importance of microRNAs in cancer has been underlined by the identification of alterations in microRNA target binding sites and the microRNA processing machinery in tumor cells. Clinical trials utilizing microRNA profiling for patient prognosis and clinical response are now underway, and the first microRNA mimic entered the clinic for cancer therapy in 2013. In this article we review the potential applications of microRNAs for the clinical assessment of patient outcome in cancer, as well as in cancer monitoring and therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., & Downward, J. (2013) · Nature · doi:10.1038/nature12785 · Cited by 255
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,630
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
miRBase: tools for microRNA genomics
Griffiths‐Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,349
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,262
Flagged first, then by citations
Research works printed but not linked: 1
- Choudhury, 2012, Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells, J. Clin. Invest., 122, 4059, 10.1172/JCI62925 · DOI
Cited by
Sorted by citations
Items 501–600 of 1,000
Xia, H., Lv, Y., Xu, C., Fu, M., Zhang, T., Yan, X., Dai, S., Xiong, Q., Zhou, Y., Wang, J., et al. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170577 · Cited by 42
Gu, H. Y., Marks, N. D., Winter, A. D., Weir, W., Tzelos, T., McNeilly, T. N., Britton, C., & Devaney, E. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006056 · Cited by 43
Chu, Y., Jiang, M., Du, F., Chen, D., Tao, Y., Xu, B., Li, X., Wang, W., Qiu, Z., Liu, H., et al. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12363 · Cited by 41
Zhu, Y., Han, Y., Tian, T., Su, P., Guan, J., Chen, J., & Cao, Y.-G. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.01.001 · Cited by 41
Cao, W., Gao, W. Z., Liu, Z., Hao, W., Li, X., Sun, Y., Tong, L., & Tang, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01537 · Cited by 41
Hirono, T., Jingushi, K., Nagata, T., Sato, M., Minami, K., Aoki, M., Harada-Takeda, A., Umehara, T., Egawa, H., Nakatsuji, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43355-8 · Cited by 43
Chen, T., & Chen, J. (2019) · eLife · doi:10.7554/elife.50848 · Cited by 43
Lin, Z., Chen, Y., Lin, Y., Lin, H., Li, H., Su, X., Fang, Z., Wang, J., Wei, Q., Teng, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77119-6 · Cited by 41
Ames, H. M., Yuan, M., Vizcaíno, M. A., Yu, W., & Rodríguez, F. J. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.177 · Cited by 41
Yin, J., Gu, T., Chaudhry, N. Y., Davidson, N. E., & Huang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1325615 · Cited by 40
RNA: The Unsuspected Conductor in the Orchestra of Macromolecular Crowding
Zacco, E., Broglia, L., Kurihara, M., Monti, M. M., Gustincich, S., Pastore, A., Plath, K., Nagakawa, S., Cerase, A., de Groot, N. S., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00575 · Cited by 41
MicroRNA regulation and analytical methods in cancer cell metabolism
Zhang, L.-F., Jiang, S., & Liu, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2508-y · Cited by 41
Recent advances in peptide nucleic acid for cancer bionanotechnology
Wu, J., Meng, Q.-C., Ren, H.-M., Wang, H., Wu, J., & Wang, Q. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.33 · Cited by 43
MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells
Zubieta, D. M. G., Hamood, M. A., Beydoun, R. S., Pall, A. E., & Kondapalli, K. C. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0209-7 · Cited by 40
Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells
Bellissimo, T., Tito, C., Ganci, F., Sacconi, A., Masciarelli, S., Martino, G. D., Porta, N., Cirenza, M., Sorci, M., Angelis, L. D., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1267-5 · Cited by 40
Luo, Y., Chen, L., Wang, G., Xiao, Y., Ju, L., & Wang, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28648 · Cited by 40
Electrochemical Nano-biosensors as Novel Approach for the Detection of Lung Cancer-related MicroRNAs
Sheervalilou, R., Shahraki, O., Hasanifard, L., Shirvaliloo, M., Mehranfar, S., Lotfi, H., Pilehvar‐Soltanahmadi, Y., Bahmanpour, Z., Zadeh, S. S., Nazarlou, Z., et al. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191001114941 · Cited by 40
Qiao, Y.-W., Zhao, X., Liu, J., & Yang, W. (2019) · Bioengineered · doi:10.1080/21655979.2019.1679698 · Cited by 40
LINC02381 Promoted Cell Viability and Migration via Targeting miR-133b in Cervical Cancer Cells
Chen, X., Zhang, Z., Ma, Y., Su, H., Xie, P., & Ran, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s237285 · Cited by 40
Yan, B., Ren, Z., Sun, J., Ding, C., & Yang, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110600 · Cited by 40
Zhan, Z., Dai, Y.-C., Li, Q., & Lv, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116129 · Cited by 40
miR-340: A multifunctional role in human malignant diseases
Huang, Z., Xu, Y., Wan, M., Zeng, X., & Wu, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.51123 · Cited by 40
Evolution in Biosensors for Cancers Biomarkers Detection: A Review
Alharthi, S. D., Bijukumar, D. R., Prasad, S., Khan, A. M., & Mathew, M. T. (2021) · Journal of Bio- and Tribo-Corrosion · doi:10.1007/s40735-020-00463-7 · Cited by 40
MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis
Zou, X., Zhu, D., Zhang, H., Zhang, S., Xin Min, Z. H. O. U., He, X., Zhu, J., & Zhu, W. (2019) · Gene · doi:10.1016/j.gene.2019.144243 · Cited by 39
Rezaee, M., Mohammadi, F., Keshavarzmotamed, A., Yahyazadeh, S., Vakili, O., Milasi, Y. E., Veisi, V., Dehmordi, R. M., Asadi, S., Ghorbanhosseini, S. S., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1152672 · Cited by 39
Applications of electrochemical impedance spectroscopy in disease diagnosis—A review
Ribeiro, J. A., & Jorge, P. A. S. (2024) · Sensors and Actuators Reports · doi:10.1016/j.snr.2024.100205 · Cited by 45
Xu, Y., Bu, X., Dai, C., & Shang, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3128-5 · Cited by 39
Matz, M., Fabritius, K., Lorkowski, C., Dürr, M., Gaedeke, J., Durek, P., Grün, J. R., Goestemeyer, A., Bachmann, F., Wu, K., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000873 · Cited by 39
MiR‐382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer
Zhou, B., Song, J., Han, T., Huang, M., Jiang, H., Qiao, H., Shi, J., & Wang, Y. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22466 · Cited by 39
Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
Keremu, A., Aini, A., Maimaitirexiati, Y., Liang, Z., Aila, P., xierela, P., Tusun, A., Moming, H., & Yusufu, A. (2017) · Bioscience Reports · doi:10.1042/bsr20170080 · Cited by 39
Yuan, Q., Cao, G., Li, J., Zhang, Y., & Yang, W. (2017) · Gene · doi:10.1016/j.gene.2017.07.031 · Cited by 39
Cavaco, A. C. M., Rezaei, M., Niland, S., & Eble, J. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112355 · Cited by 40
Catanzaro, G., Besharat, Z. M., Miele, E., Chiacchiarini, M., Pò, A., Carai, A., Marras, C. E., Antonelli, M., Badiali, M., Raso, A., et al. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12479 · Cited by 39
Simple PDMS microdevice for biomedical applications
Potrich, C., Lunelli, L., Cocuzza, M., Marasso, S. L., Pirri, C. F., & Pederzolli, C. (2018) · Talanta · doi:10.1016/j.talanta.2018.09.080 · Cited by 39
MORC4 is a novel breast cancer oncogene regulated by miR‐193b‐3p
Yang, Z., Zhuang, Q., Hu, G., & Geng, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27751 · Cited by 39
Márton, É., Lukács, J., Penyige, A., Janka, E. A., Hegedüs, L., Soltész, B., Méhes, G., Póka, R., Nagy, B., & Szilágyi, M. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.04.003 · Cited by 39
Qin, L., Lin, J., & Xie, X. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0094-1 · Cited by 39
Souza, K. C. B., Evangelista, A. F., Leal, L. F., Souza, C. D. P., Vieira, R. A. D. C., Causin, R. L., Neuber, A. C., Pessoa, D. P., Passos, G. A. S., Reis, R. M., et al. (2019) · Journal of Oncology · doi:10.1155/2019/8393769 · Cited by 39
Hu, B., Yang, X., Yang, X., & Sang, X. (2020) · Aging · doi:10.18632/aging.202306 · Cited by 39
Small Non-Coding-RNA in Gynecological Malignancies
Dwivedi, S. K. D., Rao, G., Dey, A., Mukherjee, P., Wren, J. D., & Bhattacharya, R. (2021) · Cancers · doi:10.3390/cancers13051085 · Cited by 40
Manne, A., Woods, E., Tsung, A., & Mittra, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.768009 · Cited by 39
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?
Beck, R., Stýblo, M., & Sethupathy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0845-8 · Cited by 39
You, J., Li, J., Ke, C., Xiao, Y., Lu, C., Huang, F., Mi, Y., Xia, R., & Li, Q. (2021) · Oncogene · doi:10.1038/s41388-021-01839-w · Cited by 38
Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAs
Chan, S.-F., He, C., Goh, K. K.-R., & Zou, R. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.03.005 · Cited by 38
Sathyanarayanan, A., Chandrasekaran, K. S., & Karunagaran, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.054 · Cited by 38
MotieGhader, H., Kouhsar, M. P., Najafi, A., Sadeghı, B., & Masoudi‐Nejad, A. (2017) · Molecular BioSystems · doi:10.1039/c7mb00400a · Cited by 38
Choe, M. H., Yina, Y., Kim, J., Hwang, S.-G., Han, Y.-H., & Kim, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0698-3 · Cited by 38
Protocols for the Analysis of microRNA Expression, Biogenesis, and Function in Immune Cells
Zhang, N., Hu, G., Myers, T. G., & Williamson, P. R. (2019) · Current Protocols in Immunology · doi:10.1002/cpim.78 · Cited by 39
Zheng, T., Li, D.-P., He, Z., & Zhao, S. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0943-6 · Cited by 38
Das, B., Jain, N., & Mallick, B. (2019) · Biology of the Cell · doi:10.1111/boc.201900063 · Cited by 38
Xing, L., Zhang, X., Zhang, X., & Tong, D. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29462 · Cited by 38
Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells
Prabhu, K. S., Raza, A., Karedath, T., Raza, S. S., Fathima, H., Ahmed, E. I., Kuttikrishnan, S., Therachiyil, L., Kuliński, M., Dermime, S., et al. (2020) · Cancers · doi:10.3390/cancers12020351 · Cited by 38
Label-free graphene oxide–based SPR genosensor for the quantification of microRNA21
Mujica, M. L., Zhang, Y., Fethi Bedioui, A., Gutierrez, F. A., & Rivas, G. A. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02593-w · Cited by 38
Liu, Y., Xu, Y., Ding, L., Yu, L., Zhang, B., & Wei, D. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01259-y · Cited by 38
Xu, Y., Jiang, W., Zhong, L., Li, H., Bai, L., Chen, X., Lin, Y., & Zheng, D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16072 · Cited by 38
Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy
Mittal, P., Singh, S., Sinha, R., Shrivastava, A., Singh, A. K., & Singh, I. K. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.166 · Cited by 39
Wang, M., Jing, W.-J., Wang, L., Jia, L., Ma, R.-N., Zhang, W., Shang, L., Li, X., Xue, Q., & Wang, H. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115116 · Cited by 38
miR-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the EIF5A2/MCL-1 Axis
Liu, Y., Lei, P., Qiao, H., Sun, K., Lu, X., Bao, F., Yu, R., Lian, C., Li, Y., Chen, W., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29775 · Cited by 38
Peng, Z., Pan, L., Niu, Z., Li, W. X., Dang, X., Wan, L., Zhang, R., & Yang, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19358 · Cited by 37
RNA expression signatures and posttranscriptional regulation in diabetic nephropathy
Rudnicki, M., Beckers, A., Neuwirt, H., & Vandesompele, J. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv079 · Cited by 37
miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma
Zhang, H., Alshareef, A., Wu, C., Jiao, J.-W., Sorensen, P. H. B., Lai, R. L., Xu, L., & Li, E. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw079 · Cited by 37
Malek, R. A., Wang, H., Taparra, K., & Tran, P. T. (2017) · Cells Tissues Organs · doi:10.1159/000447238 · Cited by 40
Bar, I., Merhi, A., Abdel‐Sater, F., Addi, A. B., Sollennita, S., Canon, J.-L. R., & Delrée, P. (2017) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417702849 · Cited by 37
miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4
Xu, Q., Tong, J.-L., Zhang, C.-P., Xiao, Q., Lin, X., & Xiao, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186718 · Cited by 37
Koenig, A. B., Barajas, J. M., Guerrero, M. J., & Ghoshal, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030851 · Cited by 37
UHRF1 is regulated by miR‐124‐3p and promotes cell proliferation in intrahepatic cholangiocarcinoma
Zhu, M., Wei, C., Lin, J., Dong, S., Gao, D., Chen, J., Zhao, Y., & Liu, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28586 · Cited by 37
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
Siriwardhana, C., Khadka, V. S., Chen, J. J., & Deng, Y. (2019) · BMC Cancer · doi:10.1186/s12885-018-5206-8 · Cited by 38
Grimaldi, A., & Incoronato, M. (2019) · Cancers · doi:10.3390/cancers11070901 · Cited by 37
Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer
Zhang, W., Su, X., Li, S., Liu, Z., Wang, Q., & Zeng, H. (2020) · Cancer Biomarkers · doi:10.3233/cbm-191123 · Cited by 37
Plasmonic nanobiosensors for detection of microRNA cancer biomarkers in clinical samples
Crawford, B. M., Wang, H., Stolarchuk, C., von Furstenberg, R. J., Strobbia, P., Zhang, D., Qin, X., Owzar, K., Garman, K. S., & Vo‐Dinh, T. (2020) · The Analyst · doi:10.1039/d0an00193g · Cited by 37
ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6
Li, Y., & Jiang, A. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1743150 · Cited by 37
Yu, Y., Yan, R., Chen, X., Sun, T., & Yan, J. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03865-w · Cited by 37
Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms
Gujrati, H., Ha, S., & Wang, B. (2023) · Cancers · doi:10.3390/cancers15123140 · Cited by 37
Fiori, M. E., Villanova, L., Barbini, C., Angelis, M. L. D., & Maria, R. D. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0080-x · Cited by 39
Diagnosis of Carcinogenic Pathologies through Breath Biomarkers: Present and Future Trends
Vassilenko, V., Moura, P. C., & Raposo, M. (2023) · Biomedicines · doi:10.3390/biomedicines11113029 · Cited by 36
MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4
Chen, T., Gao, F., FENG, S., YANG, T., & Chen, M. (2015) · Oncology Reports · doi:10.3892/or.2015.3978 · Cited by 36
Sun, M., Huang, F., Yu, D., Zhang, Y., Xu, H., Zhang, L., Li, L., Dong, L., Guo, L., & Wang, S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.225 · Cited by 36
Fattore, L., Sacconi, A., Mancini, R., & Ciliberto, G. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.003 · Cited by 36
Jansen, F., Schäfer, L., Wang, H., Schmitz, T., Flender, A., Schueler, R., Hammerstingl, C., Nickenig, G., Sinning, J., & Werner, N. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005270 · Cited by 37
Mensah, M., Borzi, C., Verri, C., Suatoni, P., Conte, D., Pastorino, U., Fortunato, O., Sozzi, G., & Boeri, M. (2017) · Journal of Visualized Experiments · doi:10.3791/56326 · Cited by 36
miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway
Shang, A., Lu, W., Yang, M. G., Zhou, C., Zhang, H., Cai, Z., Wang, W., Wang, W., & Wu, G. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1391825 · Cited by 36
MicroRNA-211 Loss Promotes Metabolic Vulnerability and BRAF Inhibitor Sensitivity in Melanoma
Sahoo, A., Sahoo, S. K., Joshi, P. K., Lee, B., & Perera, R. J. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.189 · Cited by 38
Souma, K., Shichino, S., Hashimoto, S., Ueha, S., Tsukui, T., Nakajima, T., Suzuki, H. I., Shand, F. H. W., Inagaki, Y., Nagase, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34839-0 · Cited by 36
Li, Y., Song, X., Liu, Z., Li, Q., Huang, M., Su, B., Mao, Y., Wang, Y., Mo, W., & Chen, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00298 · Cited by 36
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy
Luengo‐Gil, G., García-Martínez, E., Cháves-Benito, A., Conesa‐Zamora, P., Manzano, E. N., González‐Billalabeitia, E., García-Garré, E., Martínez-Carrasco, A., Vicente, V., & de la Peña, F. A. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00450-2 · Cited by 36
Liu, Y., Wang, Y., Chen, Y., Fang, X., Wen, T., Xiao, M., Chen, S., & Zhang, X. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-26663 · Cited by 36
Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients
Penyige, A., Márton, É., Soltész, B., Szilágyi, M., Póka, R., Lukács, J., Széles, L., & Nagy, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184533 · Cited by 36
MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
López, A., Overby, S. J., & Artero, R. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225600 · Cited by 36
Aberrant expression of miR-21 in patients with inflammatory bowel disease
Yan, H., Zhang, X., & Xu, Y. (2020) · Medicine · doi:10.1097/md.0000000000019693 · Cited by 36
Guan, X., & Guan, Y. (2020) · Neoplasma · doi:10.4149/neo_2020_190622n536 · Cited by 36
Long non-coding RNA HCP5 in cancer
Zou, Y., & Chen, B. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.11.015 · Cited by 36
Liu, Q., & Lei, C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111187 · Cited by 36
Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands
Hassanein, S. S., Ibrahim, S., & Abdel-Mawgood, A. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212496 · Cited by 36
Comprehensive Evolutionary Analysis of the Major RNA-Induced Silencing Complex Members
Zhang, R., Jing, Y., Zhang, H., Niu, Y., Liu, C., Wang, J., Zen, K., Zhang, C., & Li, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32635-4 · Cited by 36
Zhang, H., Zou, X., Wu, L., Zhang, S., Wang, T., Liu, P., Zhu, W., & Zhu, J. (2019) · Cancer Medicine · doi:10.1002/cam4.2676 · Cited by 35
Li, B., Hao, K., Li, M., Wang, A., Tang, H., Xu, L., Ma, C., Du, W., Sun, L., Hou, X., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101716 · Cited by 36
Role of micro RNA s Located on Chromosome Arm 10q in Malignant Gliomas
Wolter, M., Werner, T. A., Malzkorn, B., & Reifenberger, G. (2015) · Brain Pathology · doi:10.1111/bpa.12294 · Cited by 35
Liu, Y., Gao, S., Chen, X., Liu, M., Mao, C., & Fang, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-5066-2 · Cited by 35
MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy
Pourshafie, N., Lee, P. R., Chen, K., Harmison, G. G., Bott, L. C., Katsuno, M., Sobue, G., Burnett, B. G., Fischbeck, K. H., & Rinaldi, C. (2016) · Molecular Therapy · doi:10.1038/mt.2016.13 · Cited by 35
Li, Q., Li, H., Zhao, X., Wang, B., Zhang, L., Zhang, C., & Zhang, F. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19476 · Cited by 35
Metadata
- Authors
- Hayes, J., Peruzzi, P. P., & Lawler, S.
- Affiliations
- St James's University Hospital (GB)
- The Ohio State University Wexner Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Lawler, Sean
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 20
- Issue
- 8
- Pages
- 460-469
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1974254202
- Cited by
- 2,049
- References
- 79
- Citations by year
- 2026: 61 · 2025: 78 · 2024: 103 · 2023: 130 · 2022: 186 · 2021: 244 · 2020: 290 · 2019: 273 · 2018: 235 · 2017: 203 · 2016: 140 · 2015: 91 · 2014: 12
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- microRNA, cancer, biomarkers, microRNA processing, miRNA expression profiling, prognosis, cancer therapy, miRNA mimics, cancer monitoring
- MeSH terms
- Animals, Humans, Neoplasms, Prognosis, Biomarkers, Tumor, Genetic Therapy, Gene Expression Regulation, Neoplastic, MicroRNAs, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review